Free Trial

Lonza Group AG (OTCMKTS:LZAGY) Short Interest Down 49.3% in February

Lonza Group logo with Medical background
Remove Ads

Lonza Group AG (OTCMKTS:LZAGY - Get Free Report) was the target of a significant decline in short interest in the month of February. As of February 28th, there was short interest totalling 7,100 shares, a decline of 49.3% from the February 13th total of 14,000 shares. Approximately 0.0% of the company's shares are sold short. Based on an average trading volume of 53,200 shares, the days-to-cover ratio is presently 0.1 days.

Analyst Ratings Changes

Separately, Redburn Atlantic upgraded shares of Lonza Group to a "strong-buy" rating in a report on Wednesday, November 27th.

Get Our Latest Report on Lonza Group

Lonza Group Stock Up 2.6 %

LZAGY traded up $1.60 on Tuesday, reaching $63.81. 34,974 shares of the company traded hands, compared to its average volume of 56,054. The stock's 50 day moving average price is $63.75 and its 200-day moving average price is $62.29. Lonza Group has a 52-week low of $52.23 and a 52-week high of $68.29. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.38 and a current ratio of 1.52.

About Lonza Group

(Get Free Report)

Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments.

Read More

Should You Invest $1,000 in Lonza Group Right Now?

Before you consider Lonza Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lonza Group wasn't on the list.

While Lonza Group currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
Why Palantir’s Future Just Got a Massive Boost

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads